Tan Li
Fortuna: 599 M $ al 31/05/2026
Fortuna: 599 M $ al 31/05/2026
Tan Li fundó Shenzhen Hepalink Pharmaceutical Group Co. Ltd. La Sra. Li es directora ejecutiva y subdirectora general de esta empresa y socia ejecutiva de Urumqi Jintiantu Equity Investment Partnership LP. La Sra. Li también forma parte del consejo de administración de Kymab Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. y Kymab Group Ltd. Se licenció en la Universidad de Sichuan.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 408.041.280 ( 32,72 % ) | 599 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Fundador | 21/04/1998 |
Urumqi Jintiantu Equity Investment Partnership LP | Corporate Officer/Principal | 09/08/2013 |
Shenzhen Techdow Pharmaceutical Co., Ltd. | Director/Miembro de la Junta | - |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Director/Miembro de la Junta | 13/01/2014 |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Director/Miembro de la Junta | - |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Director/Miembro de la Junta | 20/01/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in production of heparin products | Health Technology |
Urumqi Jintiantu Equity Investment Partnership LP | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Distribution Services |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.